Access cutting-edge adhd - combined type treatment through this clinical trial at a research site in Baltimore. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Baltimore location
Preparing your pre-screening questions…
Access adhd - combined type specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related adhd - combined type treatment provided free
Check if you qualify for this adhd - combined type clinical trial in Baltimore, MD
No-Cost Study Care
Local to Baltimore
Convenient for MD residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
The investigators' goal is to develop neuroimaging biomarkers to predict response to treatment with methylphenidate, which then can be used in the development of novel pharmacological treatments for attention-deficit/hyperactivity disorder (ADHD). The overall objective of this study is to measure the changes in task-related neural activity related to symptoms of ADHD (measured by functional MRI) and brain glutamate levels (measured by magnetic resonance spectroscopy, MRS) after treatment with methylphenidate (MPH). This will be a double-blind crossover of methylphenidate and placebo in adults with ADHD. Participants will complete neuropsychological testing along with fMRI and MRS scans after a single dose of each treatment.
Sponsor: Johns Hopkins University
Yes, this clinical trial (NCT04781972) has an active research site in Baltimore, MD that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for adhd - combined type treatment options in Baltimore, MD, this clinical trial (NCT04781972) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Baltimore research site is actively enrolling participants for this clinical trial. You'll receive care from experienced adhd - combined type specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all adhd - combined type clinical trials near you to find additional studies recruiting in your area.
See all pulmonary embolism clinical trials recruiting in Baltimore — not just this study.
Browse Pulmonary Embolism Trials in Baltimore →